Psoriasis during interferon beta treatment for multiple sclerosis

By La Mantia Loredana   Capsoni F.  

Neurological Sciences, Vol. 31, Iss. 3, 2010-06 ,pp. : 337-339

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacodynamics of interferon beta in multiple sclerosis patients with or without serum neutralizing antibodies

By Scagnolari Carolina   Duda Petra   Bagnato Francesca   Vito Gabriella   Alberelli Alessia   Lavolpe Vito   Girardi Enrico   Durastanti Valentina   Trojano Maria   Kappos Ludwig   Antonelli Guido  

Journal of Neurology, Vol. 254, Iss. 5, 2007-05 ,pp. : 597-604

Springer Publishing Company

Access to resources Recommend Favorite

Interferon beta treatment: Bioavailability and antiviral activity in multiple sclerosis patients

By Garcia-Montojo Marta   Heras Virginia De Las   Bartolome Manuel   Arroyo Rafael   Alvarez-Lafuente Roberto  

Journal of NeuroVirology, Vol. 13, Iss. 6, 2007-11 ,pp. : 504-512

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Interferon-beta or azathioprine as add-on therapies in patients with active multiple sclerosis

By Ticha Veronika   Kalincik Tomas   Havrdova Eva  

Neurological Research, Vol. 34, Iss. 10, 2012-12 ,pp. : 923-930

Maney Publishing

Access to resources Recommend Favorite

Interferon beta in secondary progressive multiple sclerosis: Daily clinical practice

By Río J.   Tintoré M.   Nos C.   Téllez N.   Galán I.   Pelayo R.   Montalban X.  

Journal of Neurology, Vol. 254, Iss. 7, 2007-07 ,pp. : 849-853

Springer Publishing Company

Access to resources Recommend Favorite